Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC6A19 encodes the B0AT1 protein, a sodium-dependent neutral amino acid transporter located primarily in the intestinal and renal epithelial cells. It plays a critical role in the absorption and reabsorption of neutral amino acids. Mutations in SLC6A19 cause Hartnup disease, characterized by impaired neutral amino acid transport and increased urinary excretion.
Sodium-dependent symporter; couples sodium ion gradient to drive uptake of substrate across cell membranes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute Carrier Family 6 Member 19 (SLC6A19).